Illumina, Inc.

ILMN

$120.08

Name : Illumina, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $18,456,295,424.00

EPSttm : 4.45

Illumina, Inc.

$120.08

0.49%

$0.59

Float Short %

4.54

Margin Of Safety %

-13

Put/Call OI Ratio

0.29

EPS Next Q Diff

-0.23

EPS Last/This Y

12.4

EPS This/Next Y

0.28

Price

120.1

Target Price

118.61

Analyst Recom

2.5

Performance Q

18.19

Relative Volume

0.97

Beta

1.45

Ticker: ILMN

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-20	ILMN	99.5	0.18	0.64	81077
2025-10-21	ILMN	98.98	0.19	0.61	83425
2025-10-22	ILMN	97.2	0.20	0.87	83702
2025-10-23	ILMN	99.94	0.20	0.45	83920
2025-10-24	ILMN	100.11	0.20	0.71	84204
2025-10-27	ILMN	100.28	0.20	0.34	84542
2025-10-28	ILMN	98.1	0.20	0.38	86096
2025-10-29	ILMN	95.02	0.20	1.36	86448
2025-10-30	ILMN	99.05	0.20	0.71	86825
2025-10-31	ILMN	123.64	0.24	0.31	95037
2025-11-03	ILMN	120.02	0.25	0.34	98978
2025-11-04	ILMN	116.94	0.25	0.67	100524
2025-11-05	ILMN	122.48	0.25	0.32	100885
2025-11-06	ILMN	121.1	0.24	0.54	101126
2025-11-07	ILMN	121.91	0.25	0.72	101156
2025-11-10	ILMN	121.73	0.24	1.17	101194
2025-11-11	ILMN	122.68	0.25	0.07	101860
2025-11-12	ILMN	121.95	0.29	0.55	93272
2025-11-13	ILMN	119.88	0.29	0.17	93514
2025-11-14	ILMN	120.73	0.30	0.45	93297
2025-11-17	ILMN	120.13	0.29	0.41	93425
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-20	ILMN	99.50	2.8	-464.4	4.50
2025-10-21	ILMN	99.00	2.8	-507.6	4.50
2025-10-22	ILMN	97.23	2.4	-519.0	4.50
2025-10-23	ILMN	99.96	2.4	-477.4	4.50
2025-10-24	ILMN	100.09	2.4	-501.9	4.50
2025-10-27	ILMN	100.34	2.4	-500.9	4.50
2025-10-28	ILMN	97.80	2.4	-526.4	4.50
2025-10-29	ILMN	95.17	2.4	-527.7	4.50
2025-10-30	ILMN	99.01	2.4	-464.8	4.50
2025-10-31	ILMN	123.54	2.4	-276.1	4.50
2025-11-03	ILMN	120.02	43.1	-529.9	4.72
2025-11-04	ILMN	116.87	42.7	53.4	4.72
2025-11-05	ILMN	122.46	42.7	127.8	4.72
2025-11-06	ILMN	121.09	42.3	68.5	4.71
2025-11-07	ILMN	121.90	42.3	86.2	4.71
2025-11-10	ILMN	121.72	42.3	78.1	4.71
2025-11-11	ILMN	122.60	42.3	86.9	4.71
2025-11-12	ILMN	121.96	42.3	74.4	4.71
2025-11-13	ILMN	119.89	42.3	62.3	4.71
2025-11-14	ILMN	120.60	42.3	85.2	4.71
2025-11-17	ILMN	120.10	42.3	74.8	4.71
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-20	ILMN	0.43	-0.59	4.42
2025-10-21	ILMN	0.43	-0.59	4.42
2025-10-22	ILMN	0.43	-0.59	4.42
2025-10-23	ILMN	0.43	-0.59	4.42
2025-10-24	ILMN	0.43	-0.59	4.42
2025-10-27	ILMN	0.43	-0.59	4.47
2025-10-28	ILMN	0.43	-0.59	4.47
2025-10-29	ILMN	0.43	-0.59	4.47
2025-10-30	ILMN	0.43	-0.59	4.47
2025-10-31	ILMN	0.43	-0.59	4.47
2025-11-03	ILMN	0.43	-0.93	4.47
2025-11-04	ILMN	0.43	-0.93	4.47
2025-11-05	ILMN	0.45	-0.93	4.50
2025-11-06	ILMN	0.45	-0.93	4.50
2025-11-07	ILMN	0.45	-0.93	4.50
2025-11-10	ILMN	0.45	-1.07	4.50
2025-11-11	ILMN	0.45	-1.07	4.50
2025-11-12	ILMN	0.45	-1.07	4.53
2025-11-13	ILMN	0.45	-1.07	4.53
2025-11-14	ILMN	0.45	-1.07	4.53
2025-11-17	ILMN	0.01	0.52	4.54
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.34

Avg. EPS Est. Current Quarter

1.22

Avg. EPS Est. Next Quarter

1.11

Insider Transactions

0.01

Institutional Transactions

0.52

Beta

1.45

Average Sales Estimate Current Quarter

1103

Average Sales Estimate Next Quarter

1058

Fair Value

104.19

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

77.8

Max Drawdown 5-Year %

-86.2

Target Price

118.61

P/E

26.9

Forward P/E

23.93

PEG

2.44

P/S

4.28

P/B

7.72

P/Free Cash Flow

18.35

EPS

4.46

Average EPS Est. Cur. Y

4.71

EPS Next Y. (Est.)

4.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.41

Relative Volume

0.97

Return on Equity vs Sector %

2.6

Return on Equity vs Industry %

18.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.21

EBIT Estimation

74.8

Illumina, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 8970

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

stock quote shares ILMN – Illumina, Inc. Stock Price stock today

news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ILMN – Illumina, Inc. yahoo finance google finance

stock history ILMN – Illumina, Inc. invest stock market

stock prices ILMN premarket after hours

ticker ILMN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ILMN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y